Literature DB >> 27323247

In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum.

Hanna Cho1, Jae Yong Choi2, Mi Song Hwang1, You Jin Kim1, Hye Mi Lee1, Hye Sun Lee3, Jae Hoon Lee2, Young Hoon Ryu2, Myung Sik Lee1, Chul Hyoung Lyoo1.   

Abstract

OBJECTIVE: To determine the in vivo cortical spreading pattern of tau and amyloid and to establish positron emission tomography (PET) image-based tau staging in the Alzheimer disease (AD) spectrum.
METHODS: We included 195 participants (53 AD, 52 amnestic mild cognitive impairment [MCI], 23 nonamnestic MCI, and 67 healthy controls) who underwent 2 PET scans ((18) F-florbetaben for amyloid-β and (18) F-AV-1451 for tau). We assumed that regions with earlier appearances of pathology may show increased binding in a greater number of participants and acquired spreading order of tau accumulation by sorting the regional frequencies of involvement. We classified each participant into image-based tau stage based on the Z score of the composite region for each stage.
RESULTS: Tau accumulation was most frequently observed in the medial temporal regions and spread stepwise to the basal and lateral temporal, inferior parietal, posterior cingulate, and other association cortices, and then ultimately to the primary cortical regions. In contrast, amyloid accumulation was found with similar frequency in the diffuse neocortical areas and then finally spread to the medial temporal regions. The image-based tau stage correlated with the general cognitive status, whereas cortical thinning was found only in the advanced tau stages: medial temporal region in stage V and widespread cortex in stage VI.
INTERPRETATION: Our PET study replicated postmortem spreading patterns of tau and amyloid-β pathologies. Unlike the diffuse accumulation of amyloid throughout the neocortex, tau spreading occurred in a stepwise fashion through the networks. Image-based tau staging may be useful for the objective assessment of AD progression. Ann Neurol 2016;80:247-258.
© 2016 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27323247     DOI: 10.1002/ana.24711

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  185 in total

Review 1.  Biomarkers for neurodegenerative diseases.

Authors:  Oskar Hansson
Journal:  Nat Med       Date:  2021-06-03       Impact factor: 53.440

2.  [F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging.

Authors:  Marta Marquié; Michael Siao Tick Chong; Alejandro Antón-Fernández; Eline E Verwer; Nil Sáez-Calveras; Avery C Meltzer; Prianca Ramanan; Ana C Amaral; Jose Gonzalez; Marc D Normandin; Matthew P Frosch; Teresa Gómez-Isla
Journal:  Acta Neuropathol       Date:  2017-06-13       Impact factor: 17.088

3.  Longitudinal clinical, neuropsychological, and neuroimaging characterization of a kindred with a 12-octapeptide repeat insertion in PRNP: the next generation.

Authors:  Ryan A Townley; Angelina J Polsinelli; Julie A Fields; Mary M Machulda; David T Jones; Jonathan Graff-Radford; Kejal M Kantarci; Val J Lowe; Rosa V Rademakers; Matt C Baker; Neeraj Kumar; Bradley F Boeve
Journal:  Neurocase       Date:  2020-06-30       Impact factor: 0.881

4.  Assessment of Extent and Role of Tau in Subcortical Vascular Cognitive Impairment Using 18F-AV1451 Positron Emission Tomography Imaging.

Authors:  Hee Jin Kim; Seongbeom Park; Hanna Cho; Young Kyoung Jang; Jin San Lee; Hyemin Jang; Yeshin Kim; Ko Woon Kim; Young Hoon Ryu; Jae Yong Choi; Seung Hwan Moon; Michael W Weiner; William J Jagust; Gil D Rabinovici; Charles DeCarli; Chul Hyoung Lyoo; Duk L Na; Sang Won Seo
Journal:  JAMA Neurol       Date:  2018-08-01       Impact factor: 18.302

5.  Functional connectivity associated with tau levels in ageing, Alzheimer's, and small vessel disease.

Authors:  Nicolai Franzmeier; Anna Rubinski; Julia Neitzel; Yeshin Kim; Alexander Damm; Duk L Na; Hee Jin Kim; Chul Hyoung Lyoo; Hana Cho; Sofia Finsterwalder; Marco Duering; Sang Won Seo; Michael Ewers
Journal:  Brain       Date:  2019-04-01       Impact factor: 13.501

6.  Regional times to equilibria and their impact on semi-quantification of [18F]AV-1451 uptake.

Authors:  Kerstin Heurling; Ruben Smith; Olof T Strandberg; Martin Schain; Tomas Ohlsson; Oskar Hansson; Michael Schöll
Journal:  J Cereb Blood Flow Metab       Date:  2018-08-03       Impact factor: 6.200

7.  Amyloid burden accelerates white matter degradation in cognitively normal elderly individuals.

Authors:  Ashwati Vipin; Kwun Kei Ng; Fang Ji; Hee Youn Shim; Joseph K W Lim; Ofer Pasternak; Juan Helen Zhou
Journal:  Hum Brain Mapp       Date:  2019-01-03       Impact factor: 5.038

8.  Characterization of 3 Novel Tau Radiopharmaceuticals, 11C-RO-963, 11C-RO-643, and 18F-RO-948, in Healthy Controls and in Alzheimer Subjects.

Authors:  Dean F Wong; Robert A Comley; Hiroto Kuwabara; Paul B Rosenberg; Susan M Resnick; Susanne Ostrowitzki; Cristina Vozzi; Frank Boess; Esther Oh; Constantine G Lyketsos; Michael Honer; Luca Gobbi; Gregory Klein; Noble George; Lorena Gapasin; Kelly Kitzmiller; Josh Roberts; Jeff Sevigny; Ayon Nandi; James Brasic; Chakradhar Mishra; Madhav Thambisetty; Abhay Mogekar; Anil Mathur; Marilyn Albert; Robert F Dannals; Edilio Borroni
Journal:  J Nucl Med       Date:  2018-05-04       Impact factor: 10.057

9.  Simultaneous quantitative susceptibility mapping and Flutemetamol-PET suggests local correlation of iron and β-amyloid as an indicator of cognitive performance at high age.

Authors:  J M G van Bergen; X Li; F C Quevenco; A F Gietl; V Treyer; R Meyer; A Buck; P A Kaufmann; R M Nitsch; P C M van Zijl; C Hock; P G Unschuld
Journal:  Neuroimage       Date:  2018-03-13       Impact factor: 6.556

10.  Regional Tau Effects on Prospective Cognitive Change in Cognitively Normal Older Adults.

Authors:  Xi Chen; Kaitlin E Cassady; Jenna N Adams; Theresa M Harrison; Suzanne L Baker; William J Jagust
Journal:  J Neurosci       Date:  2020-11-20       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.